Loomis, Sayles & Company
DGX icon

Loomis, Sayles & Company’s Quest Diagnostics DGX Stock Holding History

Loomis, Sayles & Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-146
Closed -$20K – 771
2023
Q4 		$20K Buy
146
+52
+55% +$6.84K ﹤0.01% 681
2023
Q3 		$11K Buy
94
+18
+24% +$2.4K ﹤0.01% 754
2023
Q2 		$11K Sell
76
-24
-24% -$3.31K ﹤0.01% 716
2023
Q1 		$14K Sell
100
-172
-63% -$24.6K ﹤0.01% 764
2022
Q4 		$43K Buy
272
+259
+1,992% +$37.2K ﹤0.01% 626
2022
Q3 		$2K Sell
13
-75
-85% -$9.88K ﹤0.01% 786
2022
Q2 		$12K Sell
88
-21
-19% -$2.86K ﹤0.01% 635
2022
Q1 		$15K Sell
109
-774
-88% -$108K ﹤0.01% 658
2021
Q4 		$153K Sell
883
-10,248
-92% -$1.56M ﹤0.01% 579
2021
Q3 		$1.62M Buy
11,131
+11,059
+15,360% +$1.62M ﹤0.01% 478
2021
Q2 		$10K Buy
+72
New +$9.43K ﹤0.01% 768
2018
Q4 		– Sell
-1,184
Closed -$128K – 858
2018
Q3 		$128K Sell
1,184
-1,153
-49% -$126K ﹤0.01% 607
2018
Q2 		$257K Sell
2,337
-1,135
-33% -$118K ﹤0.01% 595
2018
Q1 		$348K Buy
3,472
+762
+28% +$78K ﹤0.01% 588
2017
Q4 		$267K Hold
2,710
– – ﹤0.01% 598
2017
Q3 		$254K Hold
2,710
– – ﹤0.01% 611
2017
Q2 		$301K Sell
2,710
-162
-6% -$17.1K ﹤0.01% 580
2017
Q1 		$282K Buy
2,872
+501
+21% +$47.8K ﹤0.01% 629
2016
Q4 		$218K Hold
2,371
– – ﹤0.01% 658
2016
Q3 		$201K Buy
2,371
+1,830
+338% +$154K ﹤0.01% 650
2016
Q2 		$44K Hold
541
– – ﹤0.01% 664
2016
Q1 		$39K Sell
541
-856
-61% -$57.4K ﹤0.01% 684
2015
Q4 		$99K Sell
1,397
-159
-10% -$10.7K ﹤0.01% 711
2015
Q3 		$96K Buy
+1,556
New +$109K ﹤0.01% 750
2014
Q2 		– Sell
-119,300
Closed -$6.91M – 754
2014
Q1 		$6.91M Buy
+119,300
New +$6.39M 0.02% 524

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Loomis, Sayles & Company's DGX Position: Q1 2024 in Review

Loomis, Sayles & Company sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 146 shares — an estimated $20K sold.

Loomis, Sayles & Company first reported a position in DGX in Q1 2014 and held it in 25 quarters. The position peaked at $6.91M in Q1 2014. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Loomis, Sayles & Company reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 146 Quest Diagnostics shares in Q1 2024, an estimated $20K.
  • Loomis, Sayles & Company first reported a position in Quest Diagnostics in Q1 2014 and held it in 25 quarters.
  • Loomis, Sayles & Company's Quest Diagnostics position peaked at $6.91M in Q1 2014.
  • 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Loomis, Sayles & Company's 13F filing for Q1 2024, filed 14 May 2024.